Results 41 to 50 of about 430,558 (143)
Cancer Antigen 125 during Pregnancy in Women without Ovarian Tumor Is Not Often Rising
Obstetrics and Gynecology International, 2018 Objective. To determine the percentage of rising serum cancer antigen (CA-125) in singleton pregnant women whose ultrasonographical findings were normal. Methods.
Rattapon Amampai, Prapaporn Suprasert
doaj +1 more source
More than 15 Years of CA 125: What is Known about the Antigen, Its Structure and Its Function
The International Journal of Biological Markers, 1998 In 1997 CA 125 celebrated its 15th anniversary. Since the discovery of OC 125, an antibody that recognizes CA 125, by Bob Bast and his colleagues, considerable progress has been made toward the development of more sensitive and more precise assay systems.
T.J. O'Brien +3 more
doaj +1 more source
The role of preoperative serum cancer antigen 125 in malignant ovarian germ cell tumors
Taiwanese Journal of Obstetrics & Gynecology, 2018 Objective: To determine the role of preoperative serum cancer antigen 125 (CA 125) in malignant ovarian germ cell tumors (MOGCTs). Materials and methods: Using information from medical databases of Asan Medical Center (Seoul, Korea), we investigated 161 ...
Ju-Hyun Kim +5 more
doaj +1 more source
Comparison of Serum CA-125 Level in Ruptured and Unruptured Tubal Pregnancies in Yazd/Iran during 2001-2006 [PDF]
Journal of Kerman University of Medical Sciences, 2009 Background & Aims: This study aimed to determine if serial measurement of serum CA-125 level could be used as a useful test in the differential diagnosis of intact and ruptured tubal pregnancies. Methods: In a single-blind prospective controlled clinical
L Sekhavat, M Mojibian, M Karimi zarchi
doaj
Comparison between Centcor CA 125 and CA 125 II assays.
European journal of gynaecological oncology, 1997 Second generation CA 125 assays are expected to replace the original CA 125 assays soon. This study compares the Centcor CA 125 II and the original Centcor CA 125 assays in 50 women: 34 with gynecologic cancers, 5 with benign conditions and 11 healthy. The serum values obtained by both assays were not statistically different and showed high correlation
G H, Eltabbakh +5 more
openaire +1 more source
Jurnal Kedokteran dan KesehatanHigh grade serous carcinoma (HGSC) of the ovary is the dominant subtype causing death from ovarian cancer. CCNE1 amplification occurs in 20% of ovarian HGSC and is associated with recurrence after platinum chemotherapy. Assessment of CCNE1 expression can
Dianli Fitriani +2 more
doaj +1 more source
Archives of Advances in BiosciencesIntroduction: Ectopic pregnancy (EP) involves implantation outside the uterus, posing risks of rupture and hemorrhagic shock. Biomarkers like CA-125 have shown potential in predicting EP progression.
Mohammad Eslami Vaghar
doaj
Gastroenterology Research and Practice, 2015 Objective. To investigate the serum level of CA-125 and its corresponding clinical significance in Chinese patients with primary BCS. Methods. Serum CA-125 was measured in 243 patients with primary BCS receiving interventional treatment in the ...
De-lei Cheng +5 more
doaj +1 more source
CA 125: Value or addiction? [PDF]
Cancer, 2010 The author challenges a recent study indicating that there is no apparent benefit in routinely measuring cancer antigen 125 (CA 125) in the follow‐up of women with ovarian cancer.
openaire +2 more sources
Menopause Review, 2011 Introduction: Ovarian cancer is a neoplasm characterised by considerable mortality. The aim of numerousstudies which have been conducted is to determine the impact of clinical and biochemical parameters onovarian cancer prognosis, survival and treatment.
Wiesława Bednarek +4 more
doaj